 | | Tuesday, April 24, 2012 |  | | | |  |
Lab & Analytical Equipment: Surplus to Ongoing Operations of Alexza Pharmaceuticals!
Please click here for more information. | 
More Top News | 
Please Join Aptuit at their Medicines Research Centre in Verona Italy
Drug Discovery and Development is an expensive and high-risk business that can take 10 years from inception to the commercialization of a new drug. Often associated with high attrition rates, it is driven by medical need, disease prevalence and likelihood of success. Drug Development has traditionally been a long and extensive process designed for a staged assessment of the safety, efficacy and manufacture of a drug candidate. On May 16, 2012, Aptuit will welcome nine distinguished representatives from academia and industry to speak at this FREE symposium where they will cover and discuss aspects and strategies to reduce risk, costs and timelines from Candidate Selection to Phase II Clinical Trials.
For a full description of this event, and to register, please go to: www.aptuit.com/verona/paradigms/introduction.aspx. | | 
More Featured News | 
2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395
Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:
1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.
Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.
To register and view the schedule of speakers by industry leader's visit our website. | | 
Vaccines Market Access in India - New Vaccine Uptake Drives Growth
• Review the current regulatory processes, pricing mechanisms, and vaccination schedule in India.
• Identify major multinational and domestic players, view their product portfolios and pipelines, and understand their expansion strategies..
• Examine the major drivers and resistors of the current Indian vaccine market and understand the key opportunities and threats facing developers.
Click Here for More Information. | 
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! |  • Pharm Country (Somerville, New Jersey)
Heron Health
Director - Evidence, Pricing & Access
Ensuring that all projects are being conducted in an efficient manner and that quality and client satisfaction is maximized at all times, and that the direction of the project and quality of the deliverables meet both the project objectives and the client needs.
• Biotech Beach (Santa Monica, California)
Astellas Pharma US
Environmental Health and Safety Officer
Will facilitate compliance with all applicable environmental, health, and safety principles, guidelines, and legal requirements; deliver, coordinate, and track lab safety training activities; create and maintain company safety practices and manuals; coordinate safety inspections and direct the EH&S program.
• Rocky Bio (Salt Lake City, Utah)
Watson Pharmaceuticals, Inc.
Manager, Regulatory Affairs Proprietary
Under general direction, functions as primary regulatory contact with regulatory authorities for assigned products and projects. Manages preparation of regulatory submissions, briefing packages and presentations for regulatory agency meetings. Determines nature, scope and format of information to be generated in order to successfully: file and maintain INDs/CTAs; file regulatory dossiers; respond to health authority inquiries; maintain product registrations and obtain international market access.
• BioMidwest (Chicago, Illinois)
Takeda Pharmaceuticals
Medical Director, Pharmacovigilance
Serves as the Global Safety Lead physician for complex, strategically important developmental programs especially those that are Phase III and IV programs. Responsible for the oversight of signal detection and risk management activities for designated global products. Ensures patient safety is adequately addressed in TGRD sponsored studies.
• Genetown (Cambridge, Massachusetts)
AVEO Pharmaceuticals, Inc.
Scientist, Pharmacology
Will lead and participate in the evaluation of antibody drug candidates in relevant in vivo models of cancer including proof of concept, target validation, PK/PD relationships as well as efficacy.
Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center! | | 
BioCapital Career Fair
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Mid-Atlantic region.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
• BioCapital Career Fair, Bethesda, MD April 25, 2012
• Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
• BioNC Career Fair, Durham, NC May 2, 2012
• Biotech Bay Career Fair, Burlingame, CA May 29, 2012
More information about BioSpace's Career Fairs
BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services | | 
Intrexon Corporation
108 T.W. Alexander Drive
PO Box 14088
Research Triangle Park, North Carolina 27709 U.S.A
Founded in 1998, Intrexon Corporation is a privately held synthetic biology company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science.
More Company Profiles | | 
 | FREE Subscription to BioPharm International
BioPharm International provides a forum for its readers to exchange practical, hands-on information for developing and manufacturing pharmaceutical products through biotechnology; and serves as a supportive, authoritative voice in the evolving business, regulatory, scientific, and technical areas of the biopharmaceutical industry. | | 
Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929 | BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217 |
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong
BioSpace.com - Life. Science. Community. | | 
• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | |  | |  |  | |
No comments:
Post a Comment